Causing an ischemic stroke potentially.

‘These improvements make the NAV6 system an outstanding embolic protection device.’ Basic safety and efficacy endpoints for the Emboshield NAV6 were met in Abbott’s PROTECT medical trial, which was made to examine carotid artery stenting with Abbott’s Emboshield systems in patients at high risk for carotid endarterectomy . Furthermore to demonstrating continued improvements in outcomes for carotid stent methods, the PROTECT study data showed a low 1.8 % composite rate of All Stroke and Death at 30 days in 220 patients.Elliott Antman, past president of the American Heart Association, called the study ‘an excellent begin in the right direction.’ ‘This is what we have to see to understand how exactly to use mobile technology to effectively modify behavior so individuals lead a far more healthy way of living,’ said Antman, who’s a professor at Harvard Medical College in Boston. ‘There are several health-related apps, and just a few possess undergone any type or sort of rigorous evaluation. This scheduled program has been proven effective using gold-standard methodology.’ However, Antman added that the scholarly study only lasted for half a year, and it remains to be seen if patients will be able to stick with their heart-healthy lifestyles.